Newsletter | September 25, 2025

09.25.25 -- 6 Key Resources For Innovative Preclinical Drug Development

Preclinical Studies Of Gene Therapy Products: Latest Trends

Gain expert insights into modeling immunosuppressive regimens, key factors in study design, and the critical role of age categories in nonhuman primate research for gene therapies.

 

Designing IND-Enabling Toxicity Studies For Complex Drug Modalities

Learn more about how we adapt and enhance conventional small molecule IND-enabling studies to align with the evolving demands of modern therapeutics.

 

Safety Assessment For Ophthalmic Products

Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials. 

 

Discovery Studies: An Agile Approach To Early Data For Quicker Decisions

This scientific journal explores the value and characteristics of discovery research and presents two case studies on biodistribution under specific experimental conditions.

 

Considerations For Nonclinical Dermal Studies — Advancing To Phase 1

Discover the complex and cutting-edge world of nonclinical dermal studies where Altasciences’ experts share groundbreaking insights that help move nonclinical dermal programs forward to Phase I clinical trials, including a compelling case study featuring the minipig model.

 

SOLUTIONS

Award-Winning Preclinical Research Services

Industry leader in preclinical safety assessments across various therapeutic areas. 30+ years of experience in full range of in vivo non-GLP and GLP studies in both rodent and non-rodent species.

• Request Information